Haverford Trust Co - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.

Quarter-by-quarter ownership
Haverford Trust Co ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$5,336,000
-1.1%
122,574
-1.0%
0.07%
+12.9%
Q1 2022$5,396,000
-8.7%
123,874
-7.5%
0.06%
-3.1%
Q4 2021$5,908,000
+17.1%
133,974
+1.5%
0.06%
+6.7%
Q3 2021$5,045,000
-54.0%
132,042
-7.7%
0.06%
-6.2%
Q2 2021$10,960,000
-2.1%
143,108
-54.4%
0.06%
-55.2%
Q1 2021$11,199,000
-5.2%
313,772
-2.2%
0.14%
-14.4%
Q4 2020$11,810,000
-3.4%
320,923
-1.2%
0.17%
-14.4%
Q3 2020$12,223,000
-18.0%
324,742
-11.1%
0.20%
-23.8%
Q2 2020$14,903,000
+11.7%
365,358
+3.7%
0.26%
-5.5%
Q1 2020$13,343,000
-19.6%
352,160
-0.3%
0.27%
+0.7%
Q4 2019$16,603,000
+2.5%
353,338
-6.9%
0.27%
-5.3%
Q3 2019$16,193,000
+4.7%
379,403
-1.8%
0.28%
+2.2%
Q2 2019$15,469,000
-4.6%
386,542
-0.4%
0.28%
-7.6%
Q1 2019$16,212,000
+13.7%
387,938
+4.0%
0.30%
-1.0%
Q4 2018$14,259,000
-10.2%
373,162
-5.6%
0.30%
+3.8%
Q3 2018$15,885,000
-57.1%
395,454
-56.9%
0.29%
-59.9%
Q2 2018$36,994,000
+5.0%
917,735
+1.8%
0.73%
+3.7%
Q1 2018$35,238,000
+14.5%
901,929
+4.0%
0.70%
+16.7%
Q4 2017$30,771,000
+1.8%
867,536
+16.5%
0.60%
-4.3%
Q3 2017$30,230,000
-5.1%
744,591
+0.8%
0.63%
-9.2%
Q2 2017$31,857,000
+3.8%
738,790
+1.4%
0.70%
-0.9%
Q1 2017$30,704,000
+18.1%
728,262
+7.9%
0.70%
+11.3%
Q4 2016$26,002,000
-13.8%
675,189
-3.5%
0.63%
-16.2%
Q3 2016$30,172,000
-0.6%
699,557
-0.1%
0.75%
-1.3%
Q2 2016$30,340,000
+2.5%
700,041
-4.1%
0.76%
-1.0%
Q1 2016$29,595,000
+3.5%
729,833
+3.0%
0.77%0.0%
Q4 2015$28,597,000
+5.5%
708,732
+0.6%
0.77%
-2.2%
Q3 2015$27,097,000
-3.5%
704,737
+4.5%
0.79%
+2.1%
Q2 2015$28,079,000
-8.9%
674,156
+0.9%
0.77%
-9.6%
Q1 2015$30,824,000
+12.9%
667,898
+4.6%
0.85%
+11.5%
Q4 2014$27,297,000
-9.3%
638,667
-2.4%
0.76%
-14.9%
Q3 2014$30,096,000
-12.4%
654,694
+1.9%
0.90%
-10.8%
Q2 2014$34,353,000
+0.9%
642,348
+0.8%
1.01%
-4.2%
Q1 2014$34,032,000
-7.3%
636,940
-7.3%
1.05%
+2.0%
Q4 2013$36,696,000
+8.3%
687,316
+1.8%
1.03%
-16.4%
Q3 2013$33,881,000
+1.1%
675,329
+0.7%
1.23%
+11.7%
Q2 2013$33,516,000670,7071.10%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2022
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 6,324,319$241,621,00032.36%
Black Creek Investment Management Inc. 10,329,349$394,684,00011.46%
Healthcare Value Capital, LLC 100,000$3,821,0007.54%
KAHN BROTHERS GROUP INC 1,353,358$51,711,809,0007.28%
EQUITY INVESTMENT CORP 2,924,326$111,738,0004.28%
Eversept Partners, LP 1,503,700$57,456,3773.99%
NKCFO LLC 269,500$10,298,0003.45%
Robinson Value Management, Ltd. 96,990$3,706,0003.31%
Keystone Financial Planning, Inc. 237,691$9,082,0003.30%
CLIFFORD CAPITAL PARTNERS LLC 93,485$3,572,0003.27%
View complete list of GLAXOSMITHKLINE PLC shareholders